Efficacy of Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Baseline HbA1c=9.0%

被引：0
|
作者：
Katz, Arie
Yeh, Helen
Sugg, Jennifer E.
Parikh, Shamik J.
List, James F.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1094-P
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [11] Reference change value for HbA1c in patients with type 2 diabetes mellitus
    Trapé, J
    Aliart, ML
    Brunet, M
    Dern, E
    Abadal, E
    Queraltó, JM
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (12) : 1283 - 1287
  • [12] Personality as a predictor of HbA1c level in patients with type 2 diabetes mellitus
    Lee, Shu-Fen
    Li, Chih-Ping
    MEDICINE, 2021, 100 (27)
  • [13] HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus
    Bing Zhu
    Le Bu
    Manna Zhang
    Aaron M. Gusdon
    Liang Zheng
    Sharvan Rampersad
    Jue Li
    Shen Qu
    Scientific Reports, 6
  • [14] ASSOCIATION OF LPA AND LEVELS OF HBA1C IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Lagou, S.
    Sianni, A.
    Sitara, K.
    Tzanni, M.
    Mougkaraki, E.
    Nikoli, E.
    Miliou, S.
    Fytrakis, N.
    Zachariadou, Z.
    Fragkou, A.
    ATHEROSCLEROSIS, 2022, 355 : E140 - E141
  • [15] HbA1c level in type 2 diabetes mellitus patients with depressive symptoms
    Apriansyah, M. A.
    Kartika, H.
    Putranto, R.
    Shatri, H.
    Mudjaddid, E.
    Kusnadi, Y.
    Shahab, A.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 : 6 - 6
  • [16] Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus
    Wu, Tzu-En
    Su, Yu-Wen
    Chen, Harn-Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [17] Reductions in HbA1c and Systolic Blood Pressure in Patients with Type 2 Diabetes Treated with Dapagliflozin
    Moran, Jason
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A309 - A309
  • [18] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Miao Yu
    Guo Yue Yuan
    Bin Zhang
    Hai Ya Wu
    Xiao Feng Lv
    Diabetes Therapy, 2020, 11 : 1147 - 1159
  • [19] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Yu, Miao
    Yuan, Guo Yue
    Zhang, Bin
    Wu, Hai Ya
    Lv, Xiao Feng
    DIABETES THERAPY, 2020, 11 (05) : 1147 - 1159
  • [20] Effects of finerenone in patients with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability and duration of diabetes
    McGill, J. B.
    Agarwal, R.
    Anker, S. D.
    Bakris, G. L.
    Filippatos, G.
    Pitt, B.
    Ruilope, L. M.
    Birkenfeld, A. L.
    Caramori, M. L.
    Brinker, M.
    Joseph, A.
    Lage, A.
    Lawatscheck, R.
    Scott, C.
    Rossing, P.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S318 - S318
12345